Journal of Clinical Oncology | ASCO Publications
网页2024年9月9日 · Journal of Clinical Oncology (JCO) is a high-impact, peer-reviewed medical journal that publishes significant clinical oncology research along with editorials, reviews, and other works that relate to the care of patients with cancer.
ASCO Clinical Practice Guidelines | Journal of Clinical Oncology
网页Clinical practice guidelines serve as a guide for doctors and outline appropriate methods of treatment and care. Guidelines can address specific clinical situations (disease-oriented) or use of approved medical products, procedures, or tests (modality-oriented). Using the best available evidence, ASCO expert panels identify and develop practice ...
2024 ASCO Annual Meeting - ASCO Daily News
网页2024年6月20日 · The ASCO Annual Meeting is the Society's yearly gathering where oncologists unveil their latest clinical research, and ASCO Daily News has you covered before, during, and after the Meeting with in-depth coverage.
Antiemetics: ASCO Guideline Update | Journal of Clinical Oncology
网页2020年7月13日 · The first ASCO guideline for antiemetics was published in 1999, 1 with updates in 2006, 2 2011, 3 2015, 4 and 2017. 5 This update of the 2017 guideline provides guidance on the use of dexamethasone as a prophylactic antiemetic in patients receiving CPIs. This guideline update addresses programmed death-1 (PD-1), programmed death 1–ligand (PD ...
Management of Stage III Non–Small-Cell Lung Cancer: ASCO …
网页2021年12月22日 · The purpose of this guideline is to help clinicians involved in the diagnosis and treatment of lung cancer accurately confirm the presence of stage III non–small-cell lung cancer (NSCLC) and offer the most appropriate treatments.
Recent Advances in the Management of Metastatic Prostate Cancer
网页2021年9月2日 · Furthermore, the incidence of metastatic prostate cancer seems to have increased in all races and age groups over the past decade. 1. Herein, we discuss the most recent advances in the management of metastatic prostate cancer and highlight recently approved agents and ongoing clinical trials. We will …
Management of Aromatase Inhibitor–Induced Musculoskeletal …
网页2020年8月11日 · Aromatase inhibitor–induced musculoskeletal symptoms (AIMSS) were first recognized as a distinct entity in 2001, 5 years after the approval of the first aromatase inhibitor, anastrozole. Musculoskeletal symptoms can severely affect patients’ quality of life and also lead to premature discontinuation of aromatase inhibitor therapy.
Current and Future Management of HER2-Positive Metastatic …
网页2021年6月2日 · Introduction Advanced breast cancer with overexpression and/or amplification of human epidermal growth factor receptor 2 (HER2) is a clinically aggressive subtype with poor survival outcomes. 1, 2 However, with the introduction of trastuzumab, the survival rates have greatly improved. 1 Trastuzumab binds to the extracellular domain IV of HER2 preventing its activation. 3 In addition, other ...
Metastatic Pancreatic Cancer: ASCO Guideline Update
网页2020年8月5日 · Learn the latest recommendations for metastatic pancreatic cancer treatment from ASCO experts based on the best available evidence.
Evidence-Based Management of Oral Mucositis - ASCO Publications
网页2020年2月3日 · The morbidity of oral mucositis includes pain, nutritional compromise, and infection risk, which potentially result in breaks or dose reductions in cancer therapy. Historically, management was focused mainly on pain control and nutritional support. However, evidence-based clinical practice guidelines for …
跳至内容